Qualigen Therapeutics Inc
Change company Symbol lookup
Select an option...
QLGN Qualigen Therapeutics Inc
AWAY ETFMG Travel Tech ETF
CO Global Cord Blood Corp
KRP Kimbell Royalty Partners LP
VIRX Viracta Therapeutics Inc
ONFO Onfolio Holdings Inc
DCPH Deciphera Pharmaceuticals Inc
MET MetLife Inc
MSM MSC Industrial Direct Co Inc
BAC Bank of America Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Qualigen Therapeutics, Inc. is a diversified life sciences company focused on developing treatments for adult and pediatric cancer. The Company's cancer therapeutics pipeline includes QN-302, QN-247 and RAS-F. QN-302 compound is a small molecule genomic quadruplex (G4) selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells. QN-247 is a deoxyribonucleic acid (DNA) coated gold nanoparticle cancer drug candidate to target various types of cancer. RAS-F is a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules for preventing mutated RAS genes’ proteins from binding to their effector proteins and preventing this binding to stop tumor growth, especially in RAS-driven tumors such as pancreatic, colorectal and lung cancers. Its pipeline also includes QN-165, a drug candidate for treating COVID-19 and other viral-based infectious diseases.

Closing Price
$1.27
Day's Change
0.0161 (1.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.28
Day's Low
1.20
Volume
(Light)
Volume:
38,230

10-day average volume:
69,761
38,230

Upcoming Events

QLGN's fiscal year ends in December
There are no upcoming events for QLGN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
November 14, 2022Q3 2022 Earnings Release-$1.00-$0.16 to -$0.10-$1.00
August 15, 2022Q2 2022 Earnings Release-$1.10-$0.18 to -$0.14-$1.80
May 13, 2022Q1 2022 Earnings Release-$1.20-$0.19 to -$0.15-$1.30
April 1, 2022Q4 2021 Earnings Release-$2.00-$0.17 to -$0.17--

Past Stock Splits

DateEvent description
November 23, 20221:10 Stock Split

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.